Demographics and long-term outcomes of children with end-stage kidney disease: A 20-year territory-wide study

被引:11
|
作者
Chan, Eugene Yu Hin [1 ]
Yap, Desmond Yat Hin [2 ]
Wong, Wilfred Hing Sang [3 ]
Ho, Tsz Wai [1 ]
Tong, Pak Chiu [1 ]
Lai, Wai Ming [1 ]
Chan, Tak Mao [2 ]
Ma, Alison Lap Tak [1 ]
机构
[1] Hong Kong Childrens Hosp, Paediat Nephrol Ctr, Kowloon, Hong Kong, Peoples R China
[2] Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Nephrol, Hong Kong, Peoples R China
[3] Univ Hong Kong, Dept Paediat & Adolescent Med, Hong Kong, Peoples R China
关键词
children; demographics; dialysis; end-stage kidney disease; mortality; transplant; RENAL REPLACEMENT THERAPY; PERITONEAL-DIALYSIS; SURVIVAL; POPULATION; GUIDELINES; REGISTRY; EUROPE;
D O I
10.1111/nep.14007
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aim To evaluate the demographics and long-term patient outcomes of children with end-stage kidney disease in Hong Kong. Methods We conducted a cohort study at the Paediatric Nephrology Centre, the designated site providing kidney replacement therapy (KRT) for children in Hong Kong. The clinical characteristics and outcomes of all children who initiated chronic KRT before 19 years, between 2001 and 2020, were analysed. Results One hundred forty-seven children (50% male) received KRT at a mean age of 11.4 +/- 5.7 years. The incidence of ESKD was 6.28 per million age-related population (pmarp). The leading cause of ESKD was congenital anomalies (33%). Ten children (7%) had pre-emptive kidney transplants, 104 (71%) and 33 (22%) patients received automated peritoneal dialysis and haemodialysis as initial KRT. The incidence of ESKD increased over time, and were 4.38, 5.07, 6.15 and 9.17 pmarp during 2001-2005, 2006-2010, 2011-2015 and 2016-2020, respectively (p = .005). Ninty-seven patients (66%) received kidney transplants and the median time to receive a kidney graft was 3.7 years (95% CI 3.1-4.3). Only 10 patients had pre-emptive kidney transplants. The mortality rate was 9.1 deaths per 1000-patient-years (95%CI 4.6-16.2). The survival probabilities at 1-, 5-, 10- and 15-year were 100%, 94.8% (95%CI 90.7-98.9%), 89.7% (95% CI 83.4%-95.9%), 87.1% (95% CI 79.3%-94.9%), respectively. Standardised mortality ratio was 54.5. 72% of deaths were due to infections. Young infants and those without kidney transplants were associated with worse survival (p < .01). Multivariate analysis demonstrated that dialysis was the only factor associated with significantly increased risk of death (HRadj 12.9, 95% CI 2.7-63.2, p = .002). Conclusion We observed an increasing incidence of paediatric ESKD in Hong Kong with considerable waiting time to kidney transplant. Mortality risk is comparable to other developed countries and is highest among dialysis population. Efforts should be made to facilitate early access to paediatric kidney transplantation in Hong Kong.
引用
收藏
页码:171 / 180
页数:10
相关论文
共 50 条
  • [41] LONG-TERM TETRACYCLINES IN PATIENTS WITH END-STAGE RENAL-DISEASE
    LEDERLE, RM
    [J]. NIEREN-UND HOCHDRUCKKRANKHEITEN, 1982, 11 (04) : 142 - 150
  • [42] Long-term urokinase treatment in end-stage coronary artery disease
    Leschke, M
    Schoebel, FC
    Jax, TW
    Schannwell, CM
    Marx, R
    Strauer, BE
    [J]. HERZ, 1997, 22 (05) : 262 - 271
  • [43] Fluctuations in Serum Creatinine Levels During Hospitalization and Long-Term End-Stage Kidney Disease and Mortality
    Efros, Orly
    Beckerman, Pazit
    Basson, Ayelet A.
    Cohen, Roy
    Klang, Eyal
    Nir, Yael Frenkel
    Soffer, Shelly
    Barda, Noam
    Grossman, Ehud
    [J]. JAMA NETWORK OPEN, 2023, 6 (08) : E2326996
  • [44] INFLUENCE OF A NUTRITIONAL EDUCATION PROGRAM ON LONG-TERM MORBIDITY AND MORTALITY IN A POPULATION WITH END-STAGE KIDNEY DISEASE
    Gonzalez Garcia, Elena
    Perez Torres, Almudena
    Auxiliadora Bajo, Maria
    Del Peso Gilsanz, Gloria
    Garcia-Llana, Helena
    Trocoli, Filomena
    Castillo, Ana
    Selgas, Rafael
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [45] Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON
    Wong, Muh Geot
    Perkovic, Vlado
    Chalmers, John
    Woodward, Mark
    Li, Qiang
    Cooper, Mark E.
    Hamet, Pavel
    Harrap, Stephen
    Heller, Simon
    MacMahon, Stephen
    Mancia, Giuseppe
    Marre, Michel
    Matthews, David
    Neal, Bruce
    Poulter, Neil
    Rodgers, Anthony
    Williams, Bryan
    Zoungas, Sophia
    [J]. DIABETES CARE, 2016, 39 (05) : 694 - 700
  • [46] Long-term risk for end-stage kidney disease and death in a large population-based cohort
    Emanuel Zitt
    Constanze Pscheidt
    Hans Concin
    Reinhard Kramar
    Raphael S. Peter
    Jan Beyersmann
    Karl Lhotta
    Gabriele Nagel
    [J]. Scientific Reports, 8
  • [47] Long-term risk for end-stage kidney disease and death in a large population-based cohort
    Zitt, Emanuel
    Pscheidt, Constanze
    Concin, Hans
    Kramar, Reinhard
    Peter, Raphael S.
    Beyersmann, Jan
    Lhotta, Karl
    Nagel, Gabriele
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [48] Predictive value of heart rate variability on long-term mortality in end-stage kidney disease on hemodialysis
    Osataphan, Nichanan
    Wongcharoen, Wanwarang
    Phrommintikul, Arintaya
    Putchagarn, Phasakorn
    Noppakun, Kajohnsak
    [J]. PLOS ONE, 2023, 18 (02):
  • [49] Pancreas-Kidney Transplantation in Recipients with Diabetes End-Stage Kidney Disease Improve Long-Term Patient Survival
    Lindahl, J. P.
    Hartmann, A.
    Midtvedt, K.
    Leivestad, T.
    Oyen, O.
    Jenssen, T.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 263 - 263
  • [50] Factors Associated with Improvement in Model for End-Stage Liver Disease after Antiviral Treatment in Patients with Chronic Hepatitis B: a Territory-wide Cohort Study
    Yip, Terry Cheuk-Fung
    Lee, Hye Won
    Wong, Vincent Wai-Sun
    Wong, Grace Lai-Hung
    Tse, Yee-Kit
    Ahn, Sang Hoon
    Chan, Henry Lik-Yuen
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 192 - 192